(A) Top and rear views of 9/64, 21/64, 32/128, and 66/256 electrode configurations. (B) Basic structure of the BCI system. The 200 targets were formed by combining 40 square luminance-modulated ...

This study presents valuable findings by reanalyzing previously published MEG and ECoG datasets to challenge the predictive nature of pre-onset neural encoding effects. The evidence supporting the ...

With the follow up of the last patient treated completed, the company is preparing trial read out for presentation at the 2026 ARVO Annual Meeting by Professor Behar-Cohen, MD, PhD, lead investigator ...

LAPNET-01 Phase 1b study shows netrin-1 blockade may overcome and prevent chemoresistance in patients with pancreatic ductal adenocarcinoma (PDAC) with locally advanced PDAC (LAPC) NP137 is the ...

Spearheaded by patient-scientist Sonia Vallabh and Eric Minikel at the Broad Institute, a new drug candidate designed to slow the progression of prion disease is entering a phase 1 clinical trial, ...

Wayfinder Biosciences, a biotechnology company using small molecules to target undruggable proteins at the RNA level, today ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

CTV never fit cleanly into campaign models built for RTB-based trading. Whether agentic AI can simplify CTV for publishers will be its first real test.

How Genera, OmegaRender and AlphaRender use AI agents to turn visual production into new infrastructure, with major ...

AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced its participation in the ...

Acrisure’s transformation focused on reengineering core processes, from client engagement through to placement, servicing, ...